Interleukin-17A (IL-17A) is a cytokine that enters the CNS and stimulates C1q expression at synapses to initiate complement-mediated synaptic pruning, which is pathologically accelerated in early AD [91, 92]. The gene discussed is IL17A; the disease is Alzheimer disease.